Pasithea Therapeutics (KTTA) Current Leases (2022 - 2024)
Pasithea Therapeutics (KTTA) posted Current Leases of $32989.0 for Q1 2024, down 59.61% sequentially from $81680.0 in Q4 2023, and down 80.0% YoY from $164974.0 in Q2 2023.
Pasithea Therapeutics (KTTA) Current Leases (2022 - 2024) Analysis & Trends
Pasithea Therapeutics has reported Current Leases for 3 years, with the latest figure at $32989.0 in Q1 2024.
- Quarterly Current Leases fell 80.0% year-over-year to $32989.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $32989.0 (down 80.0% YoY) and the FY2023 annual result came in at $81680.0, down 49.07% from the prior year.
- Current Leases declined to $32989.0 in Q1 2024 per KTTA's latest filing, from $81680.0 in the prior quarter.
- Over five years, Current Leases peaked at $258031.0 in Q3 2022 and troughed at $32989.0 in Q1 2024.
- A 3-year average of $142950.1 and a median of $162668.0 in 2022 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2024: Current Leases surged 67.3% in 2023, then tumbled 80.0% in 2024.
- Over 3 years, Current Leases stood at $160362.0 in 2022, then sank by 49.07% to $81680.0 in 2023, then plunged by 59.61% to $32989.0 in 2024.
- According to Business Quant data, Current Leases over the past three periods registered $32989.0, $81680.0, and $174471.0 for Q1 2024, Q4 2023, and Q3 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.64 Bn | 130.78 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.90 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.11 Bn | 59.93 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.83 Bn | 50.69 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.01 Bn | 36.91 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.63 Bn | 28.32 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 27.65 Bn | 9.26 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - | - |
| 10 | Pasithea Therapeutics | 16.08 Mn | 16.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 32,989.00 |
| Dec 31, 2023 | 81,680.00 |
| Sep 30, 2023 | 174,471.00 |
| Jun 30, 2023 | 169,676.00 |
| Mar 31, 2023 | 164,974.00 |
| Dec 31, 2022 | 160,362.00 |
| Sep 30, 2022 | 258,031.00 |
| Jun 30, 2022 | 101,418.00 |